Sanofi raises full-year guidance after strong first half

The French drugmaker said 2026 sales should grow around 10% at constant exchange rates, with business EPS expected to rise slightly faster than revenue.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.